Submit Deal

IMMUNOVANT SCIENCES LTD

Summary

Immunovant is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases.

Deals Overview

Total Deals2

Valued Deals2

Total Value£ 466 M

Avg. Deal Size£ 233 M

Market Context

Senior Management

Sort

Target: IMMUNOVANT SCIENCES LTD

Bidder: RTW INVESTMENTS

6 Service Providers

6 Dealmakers

£ 321 M

Value

Target: IMMUNOVANT SCIENCES LTD

Bidder: ROIVANT SCIENCES LTD

4 Service Providers

12 Dealmakers

£ 143 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy